A detailed history of Prestige Wealth Management Group LLC transactions in Exact Sciences Corp stock. As of the latest transaction made, Prestige Wealth Management Group LLC holds 28 shares of EXAS stock, worth $1,247. This represents 0.0% of its overall portfolio holdings.

Number of Shares
28
Previous 28 -0.0%
Holding current value
$1,247
Previous $2,000 50.0%
% of portfolio
0.0%
Previous 0.0%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2023

Apr 26, 2024

BUY
$65.94 - $99.04 $1,120 - $1,683
17 Added 154.55%
28 $1,000
Q3 2023

Nov 13, 2023

BUY
$65.94 - $99.04 $1,120 - $1,683
17 Added 154.55%
28 $1,000
Q2 2023

Apr 26, 2024

SELL
$62.68 - $95.05 $1,065 - $1,615
-17 Reduced 60.71%
11 $1,000
Q2 2023

Aug 11, 2023

BUY
$62.68 - $95.05 $689 - $1,045
11 New
11 $1,000

Others Institutions Holding EXAS

About EXACT SCIENCES CORP


  • Ticker EXAS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 176,960,000
  • Market Cap $7.89B
  • Description
  • Exact Sciences Corporation provides cancer screening and diagnostic test products in the United States and internationally. The company offers Cologuard, a non-invasive stool-based DNA screening test to detect DNA and hemoglobin biomarkers associated with colorectal cancer and pre-cancer. It also provides Oncotype DX, a gene expression tests for...
More about EXAS
Track This Portfolio

Track Prestige Wealth Management Group LLC Portfolio

Follow Prestige Wealth Management Group LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Prestige Wealth Management Group LLC, based on Form 13F filings with the SEC.

News

Stay updated on Prestige Wealth Management Group LLC with notifications on news.